» Articles » PMID: 29187851

Modulation of P2X7 Receptor During Inflammation in Multiple Sclerosis

Overview
Journal Front Immunol
Date 2017 Dec 1
PMID 29187851
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is characterized by macrophage accumulation and inflammatory infiltrates into the CNS contributing to demyelination. Because purinergic P2X7 receptor (P2X7R) is known to be abundantly expressed on cells of the hematopoietic lineage and of the nervous system, we further investigated its phenotypic expression in MS and experimental autoimmune encephalomyelitis conditions. By quantitative reverse transcription polymerase chain reaction and flow cytometry, we analyzed the P2X7R expression in human mononuclear cells of peripheral blood from stable and acute relapsing-remitting MS phases. Human monocytes were also challenged with pro-inflammatory stimuli such as the lipopolysaccharide, or the P2X7R preferential agonist 2'(3')-O-(4 Benzoylbenzoyl)adenosine 5'-triphosphate, before evaluating P2X7R protein expression. Finally, by immunohistochemistry and immunofluorescence confocal analysis, we investigated the P2X7R expression in frontal cortex from secondary progressive MS cases. We demonstrated that P2X7R is present and inhibited on peripheral monocytes isolated from MS donors during the acute phase of the disease, moreover it is down-regulated in human monocytes after pro-inflammatory stimulation . P2X7R is instead up-regulated on astrocytes in the parenchyma of frontal cortex from secondary progressive MS patients, concomitantly with monocyte chemoattractant protein-1 chemokine, while totally absent from microglia/macrophages or oligodendrocytes, despite the occurrence of inflammatory conditions. Our results suggest that inhibition of P2X7R on monocytes and up-regulation in astrocytes might contribute to sustain inflammatory mechanisms in MS. By acquiring further knowledge about P2X7R dynamics and identifying P2X7R as a potential marker for the disease, we expect to gain insights into the molecular pathways of MS.

Citing Articles

Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders.

Liu X, Li Y, Huang L, Kuang Y, Wu X, Ma X Front Pharmacol. 2024; 15:1450704.

PMID: 39139642 PMC: 11319138. DOI: 10.3389/fphar.2024.1450704.


Extracellular Purine Metabolism-Potential Target in Multiple Sclerosis.

Laketa D, Lavrnja I Mol Neurobiol. 2024; 61(10):8361-8386.

PMID: 38499905 DOI: 10.1007/s12035-024-04104-9.


Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.

Zheng H, Liu Q, Zhou S, Luo H, Zhang W Front Immunol. 2024; 15:1345625.

PMID: 38370420 PMC: 10869479. DOI: 10.3389/fimmu.2024.1345625.


Role of the P2 × 7 receptor in neurodegenerative diseases and its pharmacological properties.

Hu Z, Luo Y, Zhu J, Jiang D, Luo Z, Wu L Cell Biosci. 2023; 13(1):225.

PMID: 38093352 PMC: 10720200. DOI: 10.1186/s13578-023-01161-w.


Antagonism of the brain P2X7 ion channel attenuates repeated social defeat induced microglia reactivity, monocyte recruitment and anxiety-like behavior in male mice.

Biltz R, Swanson S, Draime N, Davis A, Yin W, Goodman E Brain Behav Immun. 2023; 115:356-373.

PMID: 37914101 PMC: 10807695. DOI: 10.1016/j.bbi.2023.10.011.


References
1.
Wang L, Cai W, Chen P, Deng Q, Zhao C . Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia. Glia. 2008; 57(3):307-19. DOI: 10.1002/glia.20758. View

2.
Castrichini M, Lazzerini P, Gamberucci A, Capecchi P, Franceschini R, Natale M . The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α. Eur J Immunol. 2013; 44(1):227-38. DOI: 10.1002/eji.201343353. View

3.
Domercq M, Perez-Samartin A, Aparicio D, Alberdi E, Pampliega O, Matute C . P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia. 2009; 58(6):730-40. DOI: 10.1002/glia.20958. View

4.
Oberheim N, Wang X, Goldman S, Nedergaard M . Astrocytic complexity distinguishes the human brain. Trends Neurosci. 2006; 29(10):547-53. DOI: 10.1016/j.tins.2006.08.004. View

5.
Mildner A, Huang H, Radke J, Stenzel W, Priller J . P2Y receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases. Glia. 2016; 65(2):375-387. DOI: 10.1002/glia.23097. View